“All the Way,” the heavyweight Tony contender with Bryan Cranston in the leading role, has recouped its $3.9 million capitalization costs after about 16 weeks on the boards, according to the show’s producers.
Weekly sales have been robust for the production essentially from the beginning, with the zeitgeist profile of “Breaking Bad” star Cranston helping to launch the box office momentum that was further ratcheted up with the show’s awards attention. The production’s two high-profile Tony noms are for best play and lead actor in a play, the latter for Cranston’s turn as Lyndon B. Johnson in the political drama.
The $3.9 million price tag is on the upper end of what most Broadway plays cost these days, with the show’s budget inflated in part by the production’s large cast.
Robert Schenkkan’s play centers on LBJ’s twin struggles to enact civil rights legislation and to win the presidential election in the wake of John F. Kennedy Jr.’s assassination. The title premiered at the Oregon Shakespeare Festival in 2012 ahead of a pre-Broadway run in 2013 at the American Repertory Theater in Cambridge, Mass.
Now that the Main Stem production has made it into the black, any revenue the show now brings in (above and beyond its weekly running costs) is gravy. “All the Way” ends its limited engagement June 29.